Related Experiment Video

Updated: Jul 5, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Increased adherence to cardiac standards of care during participation in cardiac disease management programs

Carter Coberley1, Greg Morrow, Matthew McGinnis

  • 1Healthways, Inc., Nashville, Tennessee 37215, USA.

Disease Management : DM
|April 23, 2008
PubMed

Insights

Cardiac disease management programs significantly improve patient adherence to essential heart medications and cholesterol management. These programs enhance cardiovascular care, likely reducing mortality risk and improving quality of life for patients with heart conditions.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Clinical Quality Improvement

Background:

  • Adherence to cardiovascular disease standards of care is crucial for reducing mortality and morbidity in patients with coronary heart disease (CHD) and heart failure (HF).
  • Effective disease management (DM) programs are essential for ensuring patients receive evidence-based treatments for cardiovascular conditions.

Purpose of the Study:

  • To evaluate the effectiveness of cardiac disease management (DM) programs in improving patient adherence to cardiovascular medications.
  • To assess the impact of DM programs on low-density lipoprotein (LDL) testing rates, LDL control, and statin use.

Main Methods:

  • A retrospective analysis of 20,202 members with CHD and/or HF was conducted, comparing data from 12 months prior to program enrollment with the first 12 months of participation.
  • Adherence to angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and beta-blockers was assessed.
  • LDL testing rates, LDL control (<100 mg/dL), and statin use were measured and analyzed.

Main Results:

  • Significant improvements in adherence to angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and beta-blockers were observed (P < 0.0001).
  • Cardiac DM programs led to significant increases in LDL testing rates and statin use (P < 0.0001).
  • A 36% relative increase in achieving LDL control and a 40% relative increase in statin use were noted within the first year of program participation.

Conclusions:

  • Participation in cardiac DM programs effectively enhances patient adherence to prescribed cardiovascular medications and adherence to care guidelines.
  • Improvements in medication adherence and LDL management are associated with better cardiovascular care, potentially leading to improved quality of life and reduced mortality risk.

Related Concept Videos

Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...